Revelle

Revelle Aesthetics is a medical technology company focused on developing precision solutions for the aesthetic market. The company's flagship product, Avéli, is an FDA-cleared device designed to provide a long-term reduction in the appearance of cellulite by identifying and manually releasing the septa bands that cause skin dimpling. Founded within the Shifamed medical innovation incubator, Revelle emphasizes evidence-based, minimally invasive procedures that deliver reproducible results for physicians and patients. The company is currently commercializing its technology across the United States, targeting the high-demand body contouring and aesthetic segment.